MedPath

Third Trimester 3D Printed Models Versus 3D Ultrasound Effects on Maternal-Fetal Attachment

Not Applicable
Completed
Conditions
Maternal-Fetal Relations
Interventions
Other: 3D printed model
Other: Placebo
Registration Number
NCT03883971
Lead Sponsor
Creighton University
Brief Summary

This study will invite healthy women with singleton pregnancies and normal 20 week ultrasounds to participate in the study that will involve completing a demographic questionnaire and measure of attachment, a 3D ultrasound, being randomized to receive a 3D printed model of the fetal face or not, and completing the attachment measure again.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
96
Inclusion Criteria
  • women
  • between19-45 years of age
  • singleton pregnancy
  • no less than 26-weeks pregnant and no more than 31-weeks pregnant at randomization
  • normal fetal anatomic survey (fas) ultrasound
  • fluent in English
Exclusion Criteria
  • additional medical or entertainment ultrasounds after the 20 week anatomic ultrasound

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
3D model3D printed modelpatient is given 3D printed model of her fetus's face
picturePlacebopatient is given a fetal picture only.
Primary Outcome Measures
NameTimeMethod
Maternal Antenatal Attachment Scale (MAAS)5 minutes

The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Creighton Univeristy

🇺🇸

Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath